Peroxiredoxins (Prx) are ~26 kDa proteins that reduce H 2 O 2 in prokaryotic and eukaryotic cells (1) (2) (3) (4) (5) (6) . Prx are redox regulated (6, 7) . A catalytic, cysteinyl sulfenic acid intermediate (PrxSOH) can be over-oxidized to a sulfinic (PrxSO 2 ) or a sulfonic form (PrxSO 3 ), which destroys peroxidase activity (2, (7) (8) (9) . The renewal of peroxidase is compromised if oxidation of PrxSOH exceeds its reduction back to Prx in cells (10, 11) . Importantly, this trait enables human 2-Cys Prx proteins to switch between an ancestral antioxidant role and a more intricate, acquired role as transducer of H 2 O 2 redox-signaling (12) (13) (14) (15) . In principle, endogenous peroxides other than H 2 O 2 might act as intracellular messengers by overoxidizing 2-Cys Prx (6) . The lipoxygenase (LOX) and cyclooxygenase (COX) enzymes are a major source of lipid hydroperoxides in human cells (16, 17) . We report that lipid hydroperoxide metabolites of arachidonic acid (HpETEs) formed by cellular 5-LOX, 12-LOX, 15-LOX-1 and COX-2 oxidize Prx 1, 2 and 3 to PrxSO 2 /SO 3 . When added exogenously to cells the regioisomeric 5-, 12-and 15-HpETEs also over-oxidized peroxiredoxins. By reversibly oxidizing 2-Cys Prx the peroxide metabolites of LOX enzymes might propagate redox signals, analogous to H 2 O 2 and NADPH oxidase (13) (14) (15) . Certain LOX enzymes redistribute readily between the cytosol, nucleus and organelle membranes of cells, and they associate with signaling (18) (19) (20) (21) and cytoskeletal proteins (18, 22) . Thus, LOX might act by a peroxiredoxin-dependent mechanism coupled to their biosynthesis of autocoid lipid mediators (23, 24) EXPERIMENTAL PRODEDURES Materials -The COX inhibitor, aspirin, the LOX inhibitor, nordihydroguauretic acid (NDGA), and porcine pancreatic phospholipase A2 (PLA 2 ) were from Sigma (St. Louis, MO). Arachidonic acid (AA) (5, 8, 11, 14-cis-eicosatetraenoic acid) was from NuChek Prep (Elysian, MN). Biotin conjugated to polyethylene oxide-maleimide was from Pierce Chemical (Rockford, IL). The COX-2 inhibitor, NS-398; the LOX inhibitor, baicalein; the lipid hydroperoxide metabolites 5-, 12-, and -15 hydroperoxy-eicosatetraenoic acid (HpETE); anti-12-LOX, anti-COX-2 and Express™ enzyme immunoassay (EIA) kits for measurement of 15(S)-hydroxy-eicosatetraenoic acid and leukotriene B 4 (LTB 4 ) were all from Cayman Chemical (Ann Arbor, MI). Correlate™ EIA kits for measurement of 12(S)-HETE were from Assay Designs (Ann Arbor, MI). Anti-5-LOX antibodies were from Transduction Laboratories (Lexington, KY). Anti-15-LOX was from Dr. Conrad (UCSD School of Medicine, San Diego, CA) and antiplatelet 12-LOX antibody (25) was from Dr. Colin Funk (Queen's University, Kingston, Ontario, Canada). Rabbit polyclonal antibodies for Prx 1, 2, 3, 4 and PrxSO 3 were from Lab Frontier (Seoul, Korea http://bio.labfrontier.com/index.asp). The commercially available anti-Prx1 (LF-PA0001) and anti-Prx2 (LF-PA0007) antibodies were raised against full length recombinant human Prx1 or Prx2 antigen purified from E coli. Anti-Prx3 (LF-PA0030) was raised against purified, recombinant human Prx3 protein antigen without the mitochondrial leader sequence. Anti-Prx4 (LF-PA0009) was raised against purified, recombinant human Prx4 protein antigen without the secretion leader sequence. Anti-PrxSO 3 was raised against a sulfonylated peptide corresponding to the active site sequence common to human Prx1-4. The antiPrxSO 3 antibody (LF-PA0004) recognizes both the sulfinic and sulfonic forms of Prx and detects over-oxidized Prx enzymes with high sensitivity and specificity, as first described by Woo et al. (10, 11) . Antibodies to PrxSO 3 are not selective for individual Prx -they recognize PrxSO 3 derived from oxidation of Prx1, 2, 3, or 4. Conversely, antibodies against the separate Prx isoforms, antiPrx1, anti-Prx2, anti-Prx3 and anti-Prx4, are not selective for the valence state of Prx -they recognize oxidized and reduced forms of Prx1-4. HRP-conjugated secondary antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). PVDF membranes and Western Lighting TM chemiluminescence reagents were from PerkinElmer Life Sciences (Boston, MA). The cell lysis buffer was 50 mM Tris, pH 7.4, 0.1M NaCl, 2 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate, and 1× Complete™ protease inhibitor (Roche Applied Science). Dulbecco's modified essential medium (DMEM) and supplements were from Invitrogen (Carlsbad, CA) and fetal calf serum (FCS) was from Hyclone (Logan, UT). (26) were used as described (27) . LOX and COX-2 enzymes were stably inserted 3' to an ecdysone response element (26, 27 
Cell Lines for

Oxidation of Prx to PrxSO 3 in Cells Treated with
Phospholipase A2 -293 EcR cells expressing 15-LOX-1 or 12-LOX were incubated for 30, 60 and 90 min in 1% v/v FCS and DMEM with 20 units/ml pancreatic PLA 2 , to determine whether metabolism of endogenous fatty acids released from cellular phospholipids leads to PrxSO 3 formation. Cells were also incubated for 60 min with 60 μM AA to compare PrxSO 3 formation via oxidation of endogenous, versus exogenous fatty acids. Cells were lysed at times specified; PrxSO 3 and Prx1 were determined by western blotting.
Oxidation of Prx to PrxSO 3 in Human Cells That
Constitutively Express LOX -Undifferentiated HL-60 human leukemia cells (ATCC, Manassas, VA) were grown in RPMI medium, 10% FCS with 2 mM glutamine. Human platelets were suspended in Ca +2 free 1% v/v FCS and DMEM. HL-60 cells (1x 10 6 cells/ml) constitutively express 5-LOX and human platelets (6 x 10 7 cells/ml) constitutively express 12-LOX. Cell suspensions were incubated for 30 min, 37 o C in 1% v/v FCS and DMEM with 0 or 30 μM AA. Cells were lysed and 5-LOX, 12-LOX, PrxSO 3 and Prx1 were determined by western blotting.
Detection of Prx Oxidation by Alkylation with
Biotin-Conjugated Maleimide -We adapted a independent method (28) to determine whether, and which, 2-Cys-Prx were co-oxidized during LOX catalysis. Briefly, 293 EcR cells expressing 15-LOX-1 were incubated for 30 min with vehicle or 60 μM AA in 1% FCS 1× DMEM. In step 1, cells were washed, lysed, frozen and reacted under vacuum for 1 h at 25º with 10 mM Nethylmaleimide (NEM) and 10 mM iodoacetic acid (IAA) in 1 ml of O 2 -depleted 50 mM sodium phosphate, pH 7.0, 1 mM EDTA, 1% Triton X-100, 5mM NaF, 50 µg/ml leupeptin and 50 µg/ml aprotinin. The cell lysate was mixed in 1% SDS for 2 h at 25º in the dark. In step 2 proteins were precipitated with 10% v/v TCA for 1 h, 4 o C. The protein precipitate was washed twice with acetone, then dissolved and reduced for 0.5 h at 50°C with 4 mM DTT in 0.1 ml of O 2 -free 50 mM Hepes, pH 7.7, 1 mM EDTA, and 2% v/v SDS. In step 3 the reduced proteins in the sample were reacted for 0.5 h at 50°C with 1 mM biotin conjugated to polyethylene oxide-maleimide in 0.9 ml of 50 mM sodium phosphate, pH 7.0,1 mM EDTA. Proteins were precipitated in 10% v/v TCA; precipitate was dissolved in 0.3 ml of 50 mM Hepes pH 7.7, 1 mM EDTA, and 2% v/v SDS. The sample was then diluted with 0.3 ml of buffer without SDS. A portion of sample containing 200 μg protein was added to 100 μL Immobilized NeutrAvidin in PBS 0.1% Tween (1.0 ml final volume). Samples were rotated 12h at 4°, centrifuged and NeutrAvidin beads were washed 2x with PBS/0.1% Tween. Laemmli loading buffer (50 μL) with 5% BME was added to the beads, boiled for 10 min to release biotinylated proteins and then fractionated by SDS-PAGE. Proteins were transferred to PVDF membranes for western blot analysis. The membrane was probed with an anti-Prx1, 2, 3 and 4 antibodies.
Two-dimensional PAGE Analysis-293
EcR cells expressing 15-LOX-1 were treated with AA as described above to oxidize Prx to PrxSO 3 . We used a modified method to prepare protein samples for two-dimensional PAGE (9) . Briefly, cells (~1 x 10 6 ) were washed once in PBS and lysed in 2D lysis buffer (8M urea, 4% CHAPS, 40mM Tris (pH 8.4), and 1X protease inhibitor cocktail) by sonication (2 x 15s at 4 o C). The lysates were centrifuged at 14,000 x g for 10 min and protein concentration was determined using a fluorometric method (Quant-iT kit, Invitrogen). Immobilized pH gradient strips (pH 3-10 NL) (Invitrogen) were soaked for 75 min in rehydration buffer (8M urea, 2% CHAPS, 20 mM DTT, 0.5% (v/v) carrier ampholyte solution (Invitrogen), and 0.005% bromophenol blue) containing sample (5 ug protein). A ZOOM IPGRunner System (Invitrogen) was used to perform isoelectric focusing (~2800Vh). The pH strips were equilibrated for second dimension SDS-PAGE according to the manufacture's protocol, which were then run on ZOOM Tris-glycine 4-20% polyacrylamide gradient gels (Invitrogen). Proteins were transferred to PVDF membrane to be visualized by immunoblot with anti-Prx 1, 2 ,3 and 4 antibodies.
Western Immunoblot-Proteins were measured using mouse anti-5-LOX (1:500), rabbit antiplatelet 12-LOX (1:1000), rabbit anti-15-LOX (1:1000), rabbit anti-COX-2 (1: 450), rabbit antiPrx1, 2, 3 or 4 (1:2000) and rabbit anti-PrxSO 3 (1:2000), followed by HRP-conjugated secondary antibody (1:4000). Chemiluminescent proteinantibody complexes were quantified with a Kodak Image Station 440™. The ratio of PrxSO 3 / Prx1 was calculated from the image density. PrxSO 3 / Prx1 ratios were expressed in arbitrary units. Bar graphs depict the mean ± S.E., for n = 3-6 separate experiments.
Statistics-Statistical significance at 95% confidence was determined by analysis of variance with Bonferroni's post-hoc test. 3 by Cellular LOX and COX-2 Catalysis -Immunoblots with isoform specific anti-Prx antibodies show that 293 EcR cells constitutively expressed Prx1, 2, 3 and 4; their levels did not change due to treatment with ponasterone or AA (Fig. 1A, lanes 1-4) . The panels for Prx1, 2, 3 and 4 in Fig. 1A represent the chemiluminescence signal at different exposure times for each separate Prx isoform, whose relative expression varies. Separate experiments showed that these proportions were ~ 30% Prx1, ~10% Prx2, ~ 60% Prx3, and ~2% Prx4.
RESULTS
Oxidation of 2-Cys Prx to PrxSO
15-LOX-1 protein was induced in EcR cells treated with ponasterone, as expected (27) (Fig.  1A, lane 1 and 2) . Prx was oxidized to PrxSO 3 during 15-LOX-1 catalysis. Quantification of PrxSO 3 is simplified by the fact that it migrates as a single band on 10-20% polyacrylamide gradient gels. Likewise, Prx1~ 26.5 kDa, Prx2 ~ 24 kDa, Prx3 ~ 27 kDa and Prx4 ~ 28 kDa all migrate closely and are not fully resolved on a 10-20% gradient polyacrylamide gel. Prx1 was used as a loading control to normalize quantitation of PrxSO 3 (Fig. 1A, lane 2) . This increase was significant (bar graph, p<0.05) compared to cells treated with vehicle (Fig. 1A,  lane 1 and 3) , or to cells expressing mutant, inactive Δ ile 662 15-LOX-1 (Fig. 1B) . The LOX inhibitors, NDGA and baicalein, each blocked PrxSO 3 formation with IC 50 ~10 μM and 3 μM respectively (Fig. 1B lane 5-10 ). Cells expressing mutant Δ ile 662 15-LOX-1 had undetectable levels of 15-HETE in their medium (<0.10 ng/ml), consistent with loss of its catalytic function.
Results were similar in 293 EcR cells expressing 12-LOX or 5-LOX. The PrxSO 3 / Prx1 ratio rose 6-9 fold when cells with 12-LOX were treated with 60 μM AA, compared to vehicle or cells not expressing 12-LOX (p<0.05, Fig. 2A, lanes 1-4) . NDGA and baicalein each inhibited PrxSO 3 formation by 12-LOX catalysis, with IC 50 ~5 μM and 3 μM, respectively ( Fig. 2A, lanes 5-10) . The PrxSO 3 / Prx1 ratio rose 5-12 fold in cells expressing 5-LOX treated with AA, compared to vehicle or control cells not expressing 5-LOX (p<0.05 Fig. 2B, lanes 1-4) . NDGA and baicalein inhibited PrxSO 3 formation by 5-LOX catalysis with IC 50 ~5 μM and 6 μM, respectively (Fig. 2B,  lanes 5-10) . We verified that NDGA and baicalein inhibited 15-LOX, 12-LOX and 5-LOX activity induced by ponasterone in 293 EcR cells [ Table  1 ].
The PrxSO 3 / Prx1 ratio rose 2-4 fold when cells expressing COX-2 were treated with 60 μM AA, compared to vehicle or cells that did not express COX-2 (p<0.05, Fig. 3, lanes 1-4) Fig. 5A , NA-pulldown). This represents oxidation of ~ 20-30 % of Prx2 and Prx3 to the corresponding PrxSOH under these conditions. Data shown in Fig. 5A represent the reversible oxidation of Prx cysteinyl thiol to sulfenic acid, which occurs through normal catalytic cycling.
We also used two dimensional gel electrophoresis and immunoblotting for individual Prx isoforms to measure Prx sulfenic and sulfonic acids, which occur from over-oxidation and inactivation of PrxSO (Fig 5B) . Vehicle-treated 293 EcR cells harboring 15-LOX-1 contained Prx1, Prx2, Prx3 and Prx4 that migrated as a single main species, with a small amount, < 5% of Prx1 and Prx3 as more acidic species. Cells treated with 10 μM ponasterone for 48 h to induce 15-LOX-1 expression, followed by incubation with 60 μM AA for 30 min contained appreciable amounts of a Prx1, Prx2 and Prx3 migrating at a more acidic position, consistent with formation of the corresponding PrxSO 2 (9) . Densitometry of the oxidized Prx species, relative to the total of both Prx species, showed formation of ~13% Prx1SO 2 , ~31% Prx2SO 2 and ~36 % Prx3SO2 (Fig 5B) . undifferentiated HL-60 human leukemia cells, which express 5-LOX; PrxSO 3 /Prx1 rose ~10-fold in 6 x10 7 human platelets, which express 12-LOX (Fig. 7) .
DISCUSSION
HpETEs, the lipid hydroperoxide metabolites of 5-LOX, 12-LOX, 15-LOX-1 or COX-2, oxidized 2-Cys Prx. PrxSO 3 formation required catalysis as shown by genetic inactivation of 15-LOX-1 (Fig.  1) , by the effects of inducer (ponasterone), substrate (AA) and inhibitor combinations on EcR 293 cells that conditionally expressed LOX enzymes ( Fig. 1 and 2 ) and by the dioxygenase activity of COX-2 acetylated by aspirin (29) (Fig.  3) . 2-Cys Prx was also overoxidized by lipid hydroperoxides added exogenously to cells (Fig.  4B) . This is consistent with the affinity of alkyl hydroperoxides (4, 8) for Prx homologs in E. coli, and the proximity of hydrophobic domains and vulnerable cysteine residues in 2-Cys Prx. There may be other reasons for the apparent differential sensitivity of Prx toward exogenously added HpETE metabolites versus H 2 O 2 . This includes factors that affect the amount and/or stability of the added compounds reaching the Prx. For instance, catalase present in the FCS would efficiently scavenge the hydrogen peroxide. Additionally, these oxidants might trigger other cellular processes that modulate Prx oxidation and reduction. It is important to note that Yang et al (9) have shown that steady-state levels of < 1 μM H 2 O 2 can overoxidize Prx1, when the H 2 O 2 is generated by glucose oxidase in situ.
For simplicity we designated oxidized Prx as PrxSO 3 ; however, it was likely a mixture of PrxSO 2 and PrxSO 3 , based on the specificity of the antibodies we used (10), and previous results by others (9, 42) . The oxidized Prx measured in our experiments consisted mainly of Prx2 and Prx3 isoforms, with some contribution by Prx1. Cellular Prx oxidation by lipid hydroperoxides was ~ 65% reversible, analogous to its oxidation by H 2 O 2 (10, 11), and PrxSO 3 was found as an oligomer whether it was formed by endogenous lipid hydroperoxides or by 1 mM H 2 O 2 administered exogenously (Fig. 6) . Recently, Phalen et al (30) reported that the oxidation state governs structural transitions in Prx2 that correlate with cell cycle arrest and recovery. Although speculative, our results suggest that LOX and COX enzymes can modulate cellular processes by a peroxiredoxindependent mechanism, which is coupled to their biosynthesis of lipid mediators (23, 24) . In other words, redox mechanisms of action by LOX and COX might be inseparable from autocoid receptormediated mechanisms, as first proposed by Brash in 1985 (23).
According to the "floodgate" model the destruction of Prx peroxidase activity, by its oxidation to PrxSO 2 / SO 3 , regulates H 2 O 2 mediated signal transduction in eukaryotes (6, 7, 13, 14) . By oxidizing Prx1, 2 and 3 the hydroperoxide metabolites of mammalian LOX enzymes might regulate PDGF and TNFα signaling, analogous to H 2 O 2 and NOX (12) (13) (14) (15) 31) . Importantly, LOX enzymes might exert localized effects by redistributing between the cytosol, nucleus and plasma membrane of cells stimulated with various agonists (19-21, 32,33) , including AA (33) . In particular, 5-LOX has an SH3 binding motif for association with the GRB2 adaptor protein involved in PDGF-Ras signaling (18) . In addition, tyrosine kinases (19) and serine / threonine kinases (35) (36) (37) can modulate the catalytic activity and sub-cellular redistribution of 5-LOX and, hypothetically, any novel functions derived from specific protein-protein partnerships.
In summary, LOXs, COXs and HpETEs should be integrated with NOXs and H 2 O 2 in the Prx "floodgate model" (6, 7) . Oxidation of Prx might explain how cells modulate the activation of LOX and COX by H 2 O 2 (38, 39) and the activation of NOX activity by AA (40, 41) . 
